Alnylam Pharmaceuticals Inc
NasdaqGS:ALNY
$ 149.96
+ $6.01 (4.18%)
$ 149.96
+ $6.01 (4.18%)
End-of-day quote: 05/01/2024

Alnylam Pharmaceuticals Inc financials at a glance

The revenue of Alnylam Pharmaceuticals Inc is reported as 1.82527 billion Dollars in the fiscal year 2023. The earnings were -1.72 Dollars per share in 2023, which was 73.54 higher than 2022. And about -0.00086 billion Dollars are reported as free cash flow in the financials of Alnylam Pharmaceuticals Inc 2023. No dividends were paid to the shareholders of the Alnylam Pharmaceuticals Inc stock NasdaqGS:ALNY in the financial year 2023.

$1.83B
Revenue
$-1.72
Earnings Per Share
83.02%
Gross Margin %
$-97.12M
Free Cash Flow
Revenue
1,825.27
Earnings Per Share
-1.72
Gross Margin %
83.02
Free Cash Flow
-97.12

Financials

Year Year TTM 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Rev. Revenue N/A $1.83B $1.04B $844.29M $492.85M $219.75M $74.91M $89.91M $47.16M $41.10M $50.56M $47.17M $66.73M $82.76M $100.04M $100.53M $96.16M $50.90M $26.93M $5.72M $4.28M
GM % Gross Margin % 84.00% 83.02% 83.73% 83.40% 84.16% 88.60% 97.59% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
OM Operating Margin -20.56% -15.43% -75.68% -83.93% -,168.09% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -,197.05% -91.04% -66.24% -41.86% -47.86% -28.95% -,183.07% -,146.68% 0.00% 0.00%
EPS Earnings Per Share $-4.11 $-1.72 $-6.50 $-6.14 $-6.38 $-6.70 $-6.21 $-5.42 $-4.79 $-3.45 $-1.88 $-1.45 $-2.11 $-1.35 $-1.04 $-1.14 $-0.64 $-2.21 $-1.09 $-1.74 $-2.75
Div. Dividends N/A $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio % 0 -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% 0 0 0 0 0 0 0 0 -0.00% 0 0
Sha. Shares N/AM 0M 124.13M 120.21M 117M 112.58M 106.26M 99.87M 86.01M 85.14M 83.76M 63.92M 61.87M 43.21M 42.34M 41.84M 41.42M 40.8M 37.47M 31.92M 20.91M
OCF Operating Cash Flow N/A $-0.86M $-,541.27M $-,643.47M $-,614.96M $-,278.43M $-,562.62M $-,382.79M $-,307.70M $-,189.14M $-,165.64M $-68.66M $-,115.61M $-87.61M $-84.34M $0.00M $65.49M $196.52M $-24.63M $0.00M $0.00M
FCF Free Cash Flow N/A $-97.12M $-,613.33M $-,718.07M $-,685.32M $-,418.58M $-,689.50M $-,487.00M $-,372.26M $-,202.09M $-,174.60M $-72.66M $-,123.96M $-88.90M $-89.07M $0.00M $54.73M $188.73M $-29.62M $0.00M $0.00M
FCFS Free Cash Flow Per Share $-0.54 $0.00 $-5.04 $-6.06 $-5.96 $-3.83 $-6.85 $-5.38 $-4.35 $-2.41 $-2.35 $-1.18 $-2.47 $-2.08 $-2.12 $-1.85 $1.33 $4.88 $-0.93 $-0.84 $-2.40